Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 64.00M | € 38.00M | € 80.00M | € 32.00M | € 41.00M |
Total Assets | € 3.30B | € 3.34B | € 3.54B | € 3.47B | € 3.54B |
Total Debt | € 1.28B | € 1.25B | € 1.17B | € 1.07B | € 1.03B |
Net Debt | € 1.22B | € 1.21B | € 1.09B | € 1.04B | € 992.00M |
Total Liabilities | € 2.57B | € 2.53B | € 2.48B | € 2.39B | € 2.39B |
Stockholders Equity | € 772.00M | € 825.00M | € 1.06B | € 1.08B | € 1.15B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |